Debulking metastases of pancreatic neuroendocrine tumors may be effective at a threshold of greater than or equal to 70%, indicating that liver debulking criteria could possibly be extended to this threshold. READ MORE

News

In concert with the peptide iRGD, nanoparticles with hollow silica cores can enhance the delivery of irinotecan to a murine model of pancreatic ductal adenocarcinoma.

READ MORE

ASCO has updated their recommendations for adjuvant treatment of surgically resected pancreatic cancer.

READ MORE

The combination of gemcitabine and capecitabine offers the best survival as adjuvant therapy for patients with resected pancreatic cancer.

READ MORE

Research in Review

Adding radiation to chemotherapy regimens may not improve overall survival in patients with locally advanced pancreatic cancer.

READ MORE

Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom.

READ MORE